Results 91 to 100 of about 9,259 (230)

Ageing patients with severe haemophilia: complications and comorbidities

open access: yesZdravniški Vestnik, 2012
Background: Advances in the treatment of haemophilia patients have led to a significant increase in life expectancy. Diseases and conditions developing now were not previously encountered in this population group as patients were dying younger ...
Saša Anžej Doma   +3 more
doaj  

Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994 [PDF]

open access: green, 1994
F. Giannelli   +9 more
openalex   +1 more source

European Principles of Nursing Care for Persons With Inherited Bleeding Disorders

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction A nurse is one of the core members of the multidisciplinary haemophilia team. However, what people with inherited bleeding disorders (PwBD) can expect from them has not yet been formally defined. Aim This project, initiated by the EAHAD Nurses Committee, aimed to establish Principles of Nursing Care (PoNC) for PwBD to promote high‐
Nanda Uitslager   +4 more
wiley   +1 more source

Consequences of factor IX mutations in 26 families with haemophilia B [PDF]

open access: bronze, 1998
Ann F. Weinmann   +2 more
openalex   +1 more source

Enhancing Engagement to Support Shared Decision Making Within Haemophilia: Development of Materials for People With Haemophilia, Caregivers and Healthcare Professionals

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Treatment decision making can be complex and challenging for people with haemophilia (PwH) and their caregivers. A shared decision‐making (SDM) approach can ensure that decisions about treatment and care incorporate patients’ beliefs, values, and preferences.
Laura Meade   +6 more
wiley   +1 more source

A USABILITY STUDY ASSESSING HANDLING AND PREFERENCE OF THE CONCIZUMAB PEN-INJECTOR IN PATIENTS WITH HAEMOPHILIA AND CAREGIVERS

open access: yesHematology, Transfusion and Cell Therapy, 2023
Introduction: Concizumab is a once-daily prophylactic treatment in development for haemophilia A or B with or without inhibitors, and it is potentially the first treatment for haemophilia patients to be delivered subcutaneously using a prefilled, multi ...
NK Rasmussen   +6 more
doaj  

Systemic lupus erythematosus caused acquired hemophilia B without evidence of factor IX inhibitors

open access: yes
Rheumatology &Autoimmunity, EarlyView.
Lifang Wang   +3 more
wiley   +1 more source

Developing a Two‐Sided Decision Box to Facilitate Shared Decision‐Making for Switching From Conventional to Pharmacokinetic‐Tailored Prophylaxis in Haemophilia

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Decision‐making in haemophilia is challenging due to the small evidence base, disease heterogeneity, and inter‐patient variability. Shared decision‐making (SDM) supports patient‐clinician decisions. Aim Creation of a two‐sided decision box facilitating SDM for haemophilia patients switching from conventional (weight‐based) to ...
Arun Keepanasseril   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy